Abiopharma

Financial Statements and Related Announcement: First Quarter Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Chen Peng

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Caecilia Chu

KRYSTAL BIOTECH, INC. (KRYS) Files Form 10-Q

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011860 <b>Size:</b> 917 KB

(75% Positive) ADMA BIOLOGICS, INC. (ADMA) Provides Update on required for ASCENIV™

(30% Negative) COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI) Reports Q2 2026 Financial Results

(50% Neutral) CNS PHARMACEUTICALS, INC. (CNSP) Announces Business Combination

Ironwood - Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)

(50% Neutral) APELLIS PHARMACEUTICALS, INC. (APLS) Announces Executive Departure

SOLV Energy to Report First Quarter 2026 Financial Results on May 12, 2026

NextEra Energy to meet with investors throughout May and June

Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output

NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers

Metropolitan Commercial Bank Expands Government Banking Platform in New Jersey with Addition of Brian Turano and Tom Kasper